Chronic obstructive pulmonary disease (COPD) is a progressive airway inflammatory
condition that is associated with accelerated decline of lung function and is characterized by …

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality,
and its prevalence is rising worldwide. Bronchodilators remain the cornerstone of COPD …

Background A combination metered-dose inhaler aerosol containing ipratropium bromide
and albuterol sulfate has been reported to be more effective than either of its components in …

PURPOSE: Patients using albuterol and ipratropium for treating chronic obstructive
pulmonary disease (COPD) can use either nebulizers or metered dose inhalers. This study …

Background Several new fixed-dose combination bronchodilators have been recently
launched, and assessing their efficacy relative to each other, and with open dual …

Chronic obstructive pulmonary disease (COPD) is a common problem among patients
presenting to primary care. This condition has multiple individual and combined treatment …

COPD is projected to be the third-leading cause of death by the year 2020.
Pharmacotherapy for COPD is palliative at best, having no impact on slowing the …

To evaluate the role of inhaled ipratropium bromide alone vs oral theophylline plus inhaled
β-agonist or the combination of all three in patients with stable COPD, the following double …

OBJECTIVE: To describe the pathogenesis of chronic obstructive pulmonary disease
(COPD) and mechanisms of benefit, formulations available, drug costs, pharmacokinetic …

Importance Chronic obstructive pulmonary disease (COPD) is a common and deadly
disease. Long-acting inhaled β-agonists and anticholinergics, first-line medications for …